Quantcast

Latest Pfizer Inc. Stories

2014-08-20 08:28:32

The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW YORK, Aug. 20, 2014 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) announces an agreement with Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) to identify and support the potential development and translation of research in the area of inflammatory bowel disease...

2014-08-14 16:26:38

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods...

2014-08-12 23:10:34

A Rise In Lipitor Lawsuit Claims Jumped In Five Months With Filings That Contend Development Of Type 2 Diabetes After Taking The Cholesterol Lowing Medication, Notes Wright & Schulte LLC Columbus, OH (PRWEB) August 12, 2014 The harmful drug attorneys at Wright & Schulte LLC have learned through a Reuters analysis that Lipitor diabetes lawsuits filed against Pfizer Inc. have spiked over the past five months primarily due to all federally filed Lipitor lawsuit claims consolidated in...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-08 12:25:01

DUBLIN, Aug. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diabetic Neuropathy Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 R&D activities in the Diabetic Neuropathy sector are growing in terms of an increase in the number of mergers and acquisitions. Big pharmaceutical companies take up later-stage products from small companies, where efficacy has already been demonstrated, thereby cutting down...

2014-07-18 12:20:30

CHICAGO, July 18, 2014 /PRNewswire/ -- Zacks Equity Research highlights Pep Boys (NYSE:PBY-Free Report) as the Bull of the Day and Buenaventura (NYSE:BVN-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onPfizer Inc. (NYSE:PFE-Free Report), Mylan (Nasdaq:MYL-Free Report) and AstraZeneca (NYSE:AZN-Free Report). http://photos.prnewswire.com/prnvar/20101027/ZIRLOGO Here is a synopsis of all five stocks: Bull of the Day: Sometimes it just...

2014-07-13 23:03:21

As Lipitor Lawsuits Await Litigation The First Bellwether Trial Has Been Scheduled For July of 2015 With Depositions to Start This August Reports Wright & Schulte LLC Columbus, OH (PRWEB) July 13, 2014 Wright & Schulte LLC has learned that the first Lipitor bellwether trial has been scheduled in July of 2015, in U.S. District Court, District of South Carolina. The Lipitor lawsuits are in the discovery process in the South Carolina federal court where District Judge Richard M....

2014-07-07 08:27:44

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 7, 2014 /PRNewswire/ -- The US markets on Thursday, July 3, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 17,068.26, up 0.54% and the NASDAQ Composite closed at 4,485.93, up 0.63%. The S&P 500 finished the session 0.55% higher at 1,985.44. During the trading session, nine out of ten sectors finished on a higher note. The S&P 500 Health Care Sector...

2014-07-02 12:26:27

LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Orphan Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_orphan_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018. One of the key factors contributing to this market growth is the shorter development timelines. The Global Orphan Drugs market has also...

2014-06-22 23:02:36

Depo Testosterone Lawsuits Against Pfizer Inc. And Its Subsidiary, Pharmacia & Upjohn Company LLC, To Be Included In Industry-Wide Consolidation of Testosterone Lawsuits Columbus, OH (PRWEB) June 22, 2014 Attorneys at Wright & Schulte LLC are pleased to announce that a federal judicial panel has denied a request by Pfizer Inc., to be excluded from a consolidation of all testosterone replacement therapy lawsuits. Pfizer contended that only four lawsuits were filed against the...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.